Combined HPV extended genotyping and automated visual evaluation
Combined HPV extended genotyping and automated visual evaluation has been studied in 1 paper since 2026: 1 observational study in people; 1 in the past year. The newest paper, Nov 1, 2026: “Extended genotyping of human papillomavirus and AI-assisted cervical visual evaluation for prediction of cervical precancer in nine resource-limited settings (PAVE): a cross-sectional study”.
1 paper studies it1 findingUpdated
1 new paper in 30 daysSee all 1 papers on combined HPV extended genotyping and automated visual evaluation
At a glance
The findings reach people, from one lab or study. 1 lab.
“The maximum AUC was 0·82 (95% CI 0·80–0·84) for CIN3+ diagnosed with ectocervical biopsy.”
- 1 lab
- Funders: Cancer Moonshot and 3 more
- Humans1
What is combined HPV extended genotyping and automated visual evaluation linked with?
1Studies link combined HPV extended genotyping and automated visual evaluation with cervical intraepithelial neoplasia grade 3 or worse.
Cervical intraepithelial neoplasia grade 3 or worse
upin humans1
1 study
Cervical intraepithelial neoplasia grade 3 or worse
upin humans1
Combined HPV extended genotyping and automated visual evaluation predicts cervical intraepithelial neoplasia grade 3 or worse in humans (CIN3+ diagnosed with ectocervical biopsy) (Maximum AUC 0.82 (95% CI 0.80–0.84)).
HumansCIN3+ diagnosed with ectocervical biopsycervixfemales